Oramed Pharmaceuticals ORMP

$ 2.33 0.87%

Quarterly report 2024-Q3
added 11-07-2024

Oramed Pharmaceuticals Total Non Current Liabilities 2011-2024 | ORMP

Annual Total Non Current Liabilities Oramed Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.44 M	4.74 M	3.84 M	7.22 M	9.96 M	11.7 M	14.3 M	13 M	37 K	36 K	31.2 K	872 K	161 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
14.3 M	31.2 K	5.42 M

Quarterly Total Non Current Liabilities Oramed Pharmaceuticals

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
4.29 M	4.34 M	4.38 M	4.44 M	4.49 M	4.59 M	4.66 M	4.74 M	4.76 M	2.84 M	3.68 M	3.84 M	4.8 M	5.55 M	4.1 M	7.02 M	7.22 M	7.22 M	7.22 M	9.34 M	9.96 M	9.96 M	9.96 M	10.6 M	11.7 M	11.7 M	11.7 M	13.7 M	14.3 M	14.3 M	14.3 M	16.2 M	13 M	13 M	13 M	38 K	37 K	37 K	37 K	36 K	36 K	36 K	36 K	31.9 K	31 K	31.2 K	31.2 K	240 K	872 K	872 K	872 K	161 K	161 K	161 K	161 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
16.2 M	31 K	5.36 M